Powers Faster Runs and Smaller Sample Batching for High-Throughput Applications In January 2017, Illumina launched the NovaSeq 6000 Sequencing System. With unmatched scalable throughput, tremendous flexibility for a range of applications, and streamlined operation, the NovaSeq 6000 is the most powerful high-throughput Illumina sequencing system to date. It is uniquely positioned to help users discover more [...]

Development of new software will improve treatment options for patients Cambridge, United Kingdom and Dublin, Ireland – New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological [...]

UK Science and Industry collaboration successfully shows optical processing technology performing genetic sequence alignment significantly reducing HPC power consumption GLASSHOUGHTON, WEST YORKSHIRE, U.K. and NORWICH, U.K.– Optalysys Ltd. (@Optalysys), a start-up commercialising light-speed optical coprocessors for AI/deep learning, and world-leading genomic research institute The Earlham Institute, EI, (@EarlhamInst), today announced the successful completion of the Genetic [...]

Anton Paar, the world leader in measuring density, concentration, or dissolved CO2, has acquired Quantachrome which adds know-how in the analysis of particle surface areas, porosity and density of solids to the portfolio of 150+ analytical solutions BOYNTON BEACH, Fla. -- Quantachrome and Anton Paar finished the purchasing process on February 9 at the Quantachrome headquarters in Boynton Beach, Florida. The [...]

Merger brings together Oxford, UK and Boston, MA companies offering cutting-edge research tools Absolute Antibody Ltd., an Oxford, UK-based company with a vision to make recombinant antibody technology accessible to all, and Kerafast Inc., a Boston, MA-based company with a mission to facilitate access to unique laboratory-made reagents, today announced a merger of the two [...]

Almac Diagnostics selects DNAnexus for NGS-driven adaptive trial design to optimize and de-risk clinical trials, enabling the use of biomarkers in refining participant selection. MOUNTAIN VIEW, Calif. & CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--DNAnexus, the global leader in biomedical informatics and data management, today announced the availability of its Clinical Trial Solution (CTS) which streamlines the use [...]

Gaithersburg, MD — Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, announces the opening of its new headquarters and its research facilities in Gaithersburg, Maryland. CEO Steen Sondergaard Nissen, commenting on the move: “After many years of research and incubation at the University of Cincinnati facilities, we achieved a level of scale in both [...]

Mountain View, CA—To advance the understanding of cell diversity and how that diversity impacts complex cellular functions including interactions with other cells and molecules, growth, and disease states, Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce the launch of the SMARTer ICELL8 cx [...]

NEB® scientists, collaborators and customers to showcase data on new and upcoming NEBNext® technologies, including enzymatic DNA fragmentation, target enrichment, single cell RNA sequencing, and methylation analysis Ipswich, MA — Can an enzyme-based approach reliably and randomly generate DNA fragments for all GC contents and input amounts? How can each step in the next generation sequencing (NGS) library [...]

The new TW 3000/2 "Smart Tunnel" represents an innovative approach to high reprocessing capacity instrument washer disinfectors with a productivity of up to 62 DIN 1/1 net trays per hour. With its simple and clever concept, this double chamber tunnel washer disinfector easily reaches the highest productivity/space and productivity/cost ratios in the market. The new standard for [...]